Skip to main content
Toggle navigation
Login
Search
Home
Schedule at a Glance
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
N
Nacev, Benjamin
University of Pittsburgh Hillman Cancer Center
Benjamin Nacev Basic Science Award
Location: The Auditorium, Level 3
Benjamin Nacev
Favorite
Session 15: Awards Session
Location: The Auditorium, Level 3
Benjamin Nacev
Favorite
Nadel, Helen
Lucile Packard Children’s Hospital at Stanford University
Paper 18 - PREOPERATIVE RADIOTHERAPY IN PATIENTS WITH LOCALIZED EWING SARCOMA TREATED ON AEWS1031: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Location: The Auditorium, Level 3
Helen Nadel
Favorite
Naess, Stine
Breakfast - Introduction
Location: Wicklow Hall 2, Level 2
Stine Naess
Favorite
Nakashima, Jonathan
Certis Oncology
Paper 26 - A FIRST-IN-HUMAN STUDY OF CDK9 INHIBITOR KB-0742 DEMONSTRATES PRELIMINARY EVIDENCE OF CLINICAL ACTIVITY IN TRANSCRIPTIONALLY ADDICTED SARCOMAS
Location: The Auditorium, Level 3
Jonathan Nakashima
Favorite
Napolitano, Andrea
The Royal Marsden NHS, London, UK
Paper 59 - INTERNATIONAL MULTICENTER RETROSPECTIVE STUDY FROM THE ULTRA-RARE SARCOMA WORKING GROUP ON LOW-GRADE FIBROMYXOID SARCOMA AND SCLEROSING EPITHELIOD FIBROSARCOMA: OUTCOME OF PRIMARY LOCALISED DISEASE
Location: The Auditorium, Level 3
Andrea Napolitano
Favorite
Narasimhan, Supraja
Deciphera Pharmaceuticals, LLC
Paper 27 - SAFETY AND EFFICACY UPDATES FROM A PHASE 1 STUDY OF VIMSELTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR
Location: The Auditorium, Level 3
Supraja Narasimhan
Favorite
Nash, Joshua
The Hospital for Sick Children
Paper 09 - MULTISCALE TRANSCRIPTOMICS REVEALS THE OVERARCHING LANDSCAPE OF MESENCHYMAL NEOPLASMS AND BIOLOGICALLY MEANINGFUL SUBTYPES
Location: The Auditorium, Level 3
Joshua Nash
Favorite
Naveda, Alissette
Sylvester Comprehensive Cancer Center, University of Miami
Paper 63 - CTDNA-GUIDED SUNITINIB AND REGORAFENIB THERAPY FOR GASTROINTESTINAL STROMAL TUMOR (GIST)
Location: The Auditorium, Level 3
Alissette Naveda
Favorite
Neamati, Nouri
University of Michigan
Paper 38 - THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA VIABILITY VIA REGULATION OF α-KETOGLUTARATE DEHYDROGENASE ACTIVITY
Location: The Auditorium, Level 3
Nouri Neamati
Favorite
Neilson, John
Medical College of Wisconsin
Paper 19 - THE IMPACT OF HYPOFRACTIONATED PRE-OPERATIVE RADIATION THERAPY ON TUMOR-INFILTRATING LYMPHOCYTES IN EXTREMITY SOFT TISSUE SARCOMAS
Location: The Auditorium, Level 3
John Neilson
Favorite
Nemat-Gorgani, Neda
Stanford University
Paper 10 - INTEGRATING SPATIAL TUMOR PROFILING AND CTDNA ANALYSIS IDENTIFIES EVOLUTIONARY PRESSURES DURING SARCOMA DEVELOPMENT AND RADIOTHERAPY
Location: The Auditorium, Level 3
Neda Nemat-Gorgani
Favorite
Nessim, Carolyn
Department of Surgery, University of Ottawa
Paper 78 - A NOVEL SURGICAL COMPLEXITY SCORE TO PREDICT POSTOPERATIVE MORBIDITY FOR PRIMARY RETROPERITONEAL SARCOMA: THE FIRST TARPSWG STUDY FROM THE PROSPECTIVE RESAR REPOSITORY
Location: The Auditorium, Level 3
Carolyn Nessim
Favorite
Netherton, Tucker
MD Anderson Cancer Center
Paper 90 - THE IMPACT OF TUMOR LOCATION AND RADIATION DOSE TO BOWEL ON THE RISK OF DEVELOPING GASTROINTESTINAL TOXICITIES WHEN TREATING ABDOMINOPELVIC SOFT TISSUE SARCOMAS WITH PREOPERATIVE RADIATION
Location: The Auditorium, Level 3
Tucker Netherton
Favorite
Ng, Deanna
University of Toronto
Paper 80 - THE PET-RPS STUDY: A PROSPECTIVE EVALUATION OF PET-MR IN PREDICTING RESPONSE TO PREOPERATIVE CHEMOTHERAPY FOR PRIMARY RETROPERITONEAL SARCOMA (RPS)
Location: The Auditorium, Level 3
Deanna Ng
Favorite
Nguyen, Callistus
MD Anderson Cancer Center
Paper 90 - THE IMPACT OF TUMOR LOCATION AND RADIATION DOSE TO BOWEL ON THE RISK OF DEVELOPING GASTROINTESTINAL TOXICITIES WHEN TREATING ABDOMINOPELVIC SOFT TISSUE SARCOMAS WITH PREOPERATIVE RADIATION
Location: The Auditorium, Level 3
Callistus Nguyen
Favorite
Nicholas, Garth
Ottawa Hospital Research Institute
Paper 34 - A PHASE II STUDY OF DURVALUMAB AND TREMELIMUMAB IN PATIENTS WITH ADVANCED OSTEOSARCOMA AND UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Location: The Auditorium, Level 3
Garth Nicholas
Favorite
Nielsen, Torsten
Department of Pathology and Laboratory Medicine, University of British Columbia
Paper 34 - A PHASE II STUDY OF DURVALUMAB AND TREMELIMUMAB IN PATIENTS WITH ADVANCED OSTEOSARCOMA AND UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Location: The Auditorium, Level 3
Torsten Nielsen
Favorite
Paper 88 - HETEROGENEITY IN CHROMATIN STATES DEFINE A DISEASE SPECTRUM IN SYNOVIAL SARCOMA
Location: The Auditorium, Level 3
Torsten Nielsen
Favorite
Nordby, Kenneth
Oslo universitetssykehus
Happy Walls
Location: Wicklow Hall 2, Level 2
Kenneth Nordby
Favorite
Norry, Elliot
Adaptimmune
Paper 30 - OUTCOMES OF PATIENTS WITH ADVANCED SYNOVIAL SARCOMA TREATED WITH AFAMITRESGENE AUTOLEUCEL ("AFAMI-CEL")
Location: The Auditorium, Level 3
Elliot Norry
Favorite
Noujaim, Jonathan
Hôpital Maisonneuve-Rosemont and McGill University Health Center
Paper 05 - REFERENCE SYSTEM OPTIMIZATION, INITIAL ANALYSES OF THE IMPLEMENTATION OF A PROVINCIAL SARCOMA NETWORK
Location: The Auditorium, Level 3
Jonathan Noujaim
Favorite
Paper 52 - REAL-WORD EXPERIENCE OF SORAFENIB AND PAZOPANIB IN PATIENTS WITH DESMOID TUMORS: A CANSARCC STUDY
Location: The Auditorium, Level 3
Jonathan Noujaim
Favorite
Novak, Marko
Department of Surgery, Institute of Oncology Ljubljana
Paper 78 - A NOVEL SURGICAL COMPLEXITY SCORE TO PREDICT POSTOPERATIVE MORBIDITY FOR PRIMARY RETROPERITONEAL SARCOMA: THE FIRST TARPSWG STUDY FROM THE PROSPECTIVE RESAR REPOSITORY
Location: The Auditorium, Level 3
Marko Novak
Favorite
